tiprankstipranks
Trending News
More News >
Fate Therapeutics Inc (FATE)
:FATE
US Market

Fate Therapeutics (FATE) Technical Analysis

Compare
1,172 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Fate Therapeutics Inc’s (FATE) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Fate Therapeutics Inc is a Sell.
Fate Therapeutics Inc’s (FATE) 20-Day exponential moving average is 0.96, while Fate Therapeutics Inc’s (FATE) share price is $1.11, making it a Buy.
Fate Therapeutics Inc’s (FATE) 50-Day exponential moving average is 1.09, while Fate Therapeutics Inc’s (FATE) share price is $1.11, making it a Buy.

Fate Therapeutics (FATE) Pivot Points

Apr 19, 2025, 04:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.84
0.94
0.99
1.09
1.14
1.24
1.29
Fibonacci
0.94
0.99
1.03
1.09
1.14
1.18
1.24
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (FATE) Moving Averages

Apr 19, 2025, 04:47 AM
Period
Simple
Exponential
MA5
1.05Buy
1.05Buy
MA10
0.97Buy
0.99Buy
MA20
0.90Buy
0.96Buy
MA50
1.05Buy
1.09Buy
MA100
1.44Sell
1.47Sell
MA200
2.46Sell
2.32Sell
Fate Therapeutics Inc’s (FATE) 10-Day exponential moving average is 0.99, while Fate Therapeutics Inc’s (FATE) share price is $1.11, making it a Buy.
Fate Therapeutics Inc’s (FATE) 100-Day exponential moving average is 1.47, while Fate Therapeutics Inc’s (FATE) share price is $1.11, making it a Sell.
Fate Therapeutics Inc’s (FATE) stock price is $1.11 and Fate Therapeutics Inc’s (FATE) 50-day simple moving average is 1.05, creating a Buy signal.
Fate Therapeutics Inc’s (FATE) stock price is $1.11 and Fate Therapeutics Inc’s (FATE) 100-day simple moving average is 1.44, creating a Sell signal.
Fate Therapeutics Inc’s (FATE) stock price is $1.11 and Fate Therapeutics Inc’s (FATE) 200-day simple moving average is 2.46, creating a Sell signal.

Fate Therapeutics (FATE) Technical Indicators

Apr 19, 2025, 04:47 AM
Name
Value
Implied Action
RSI (14)
57.57
Neutral
STOCH (9,6)
84.93
Sell
STOCHRSI (14)
85.11
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
21.75
Neutral
Williams %R
-13.49
Sell
CCI (14)
153.98
Sell
ATR (14)
0.13
-
Ultimate Oscillator
56.24
Neutral
ROC
30.59
Buy
Fate Therapeutics Inc’s (FATE) Relative Strength Index (RSI) is 57.57, creating a Neutral signal.
Fate Therapeutics Inc’s (FATE) Trend Strength Indicator (ADX) is 21.75, creating a Neutral signal.
Fate Therapeutics Inc’s (FATE) Commodity Channel Index (CCI) is 153.98, creating a Sell signal.
Fate Therapeutics Inc’s (FATE) Price Rate of Change (ROC) is 30.59, creating a Buy signal.

FAQ

Is FATE a Buy, Hold, or Sell?
Based on FATE’s technical indicators, FATE is a Hold.
    What is FATE’s RSI (14)?
    FATE’s RSI (14) is 57.57, which suggests FATE is a Neutral.
      What is FATE’s MACD?
      FATE’s MACD is <0.01, which suggests FATE is a Sell.
        What is FATE’s 5-day moving average?
        FATE’s 5-day moving average is 1.05, which suggests FATE is a Buy.
          What is FATE’s 20-day moving average?
          FATE 20-day moving average is 0.90, which suggests FATE is a Buy.
            What is FATE’s 50-day moving average?
            FATE’s 50-day moving average is 1.05, which suggests FATE is a Buy.
              What is FATE’s 200-day moving average?
              FATE’s 200-day moving average is 2.46, which suggests FATE is a Sell.
                What is FATE’s Williams % R (14)?
                FATE’s Williams % R (14) is -13.49, which suggests FATE is a Sell.
                  What is FATE’s CCI (14)?
                  FATE’s CCI (14) is 153.98, which suggests FATE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis